Trademarkia Logo

Australia

AU$
Trademark Search
BIOPROGNOSTIC

View On IPO.GOV.AU

BIOPROGNOSTIC
Cancelled: Cancelled at the request of IB

Last updated on 26 Feb 2025

Owner Info

Renalytix AI, Inc.

1460 Broadway

New York NY 10036, UNITED STATES OF AMERICA

Serial Number

2266092 filed on 11 Jan 2022

Correspondent

Cooley LLP, Susan Piascik Christoff Cooley LLP

1299 Pennsylvania Ave., NW, Suite 700,

Washington DC 20004,

UNITED STATES OF AMERICA

BIOPROGNOSTIC

Classification Information

Class [005]
Medical diagnostic blood testing reagents and assays for predicting, identifying and determining the presence and stage of kidney, heart, and liver di Read More

Class [010]
Blood test collection kit comprised of blood collection bag, holder for medical sample tubes, vials, and test trips, and medical sample tubes, vials, Read More

Class [042]
Development of new technology for others in the field of medical devices and medical diagnostic apparatuses for predicting, identifying and determinin Read More

Class [044]
Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and th Read More

Mark Details

Serial Number

2266092

Registered On

11 Jan 2022

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)

Date

12 Jul 2021

Mark Type

US

Legal History

Show more

Status DateAction Taken
26th Feb 2025Status change to Voided
12th Jul 2022International Registration in Australia Protected correspondence sent
11th Jul 2022IP Right Registration Published
11th Jul 2022Status change to Registered/Protected
4th May 2022Application Accepted correspondence sent
3rd May 2022IP Right has been Examined
3rd May 2022IP Right Acceptance Published
3rd May 2022Status change to Accepted
28th Apr 2022Examination expedited
28th Apr 2022Awaiting examination